To get further insights into miR-342 expression in myeloid leukemia, we analyzed a small RNA sequencing data set of AML patients, grouped based on the mutational status of the AML driver gene FLT3, in comparison to healthy controls (n = 17) [41]. The gene discussed is FLT3; the disease is acute myeloid leukemia.